Close Menu

HELSINKI — Nightingale Health this week rolled out a consumer-facing blood testing service with the aim of giving people access to data to help them better manage their health.

The Finnish biotechnology firm also announced plans to raise up to €80 million ($89 million) in the coming year to support its growth, as well as partnerships with firms in Japan around deploying the new service there.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.